Continuous diphenhydramine infusion and imatinib for KIT-D816V-negative mast cell activation syndrome: a case report

Continuous diphenhydramine infusion and imatinib for KIT-D816V-negative mast cell activation syndrome: a case report

Abstract Background We present the first full case report of the treatment of mast cell activation syndrome with continuous diphenhydramine infusion, which resulted in the improvement of anaphylactic reactions and a decrease in hospital readmission. Furthermore, the patient received imatinib in the...

Full description

Bibliographic Details
Main Authors: Faizan Malik, Naveed Ali, Syed Imran Mustafa Jafri, Ali Ghani, Mohsin Hamid, Margot Boigon, Christian Fidler
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Journal of Medical Case Reports
Subjects:
Mastocytosis
Mast cell activation disease
Mast cell activation syndrome
Continuous diphenhydramine infusion
Imatinib
Paucity of controlled trials
Online Access:http://link.springer.com/article/10.1186/s13256-017-1278-3

Internet

http://link.springer.com/article/10.1186/s13256-017-1278-3

Similar Items